wellrank.ai
Hims & Hers Health logo

Hims & Hers Health

First cited by AI Jun 13, 2026
forhims.com

Surfaced organically in AI answers about ozempic. Not yet profiled.

Hims & Hers Health is losing the AEO war.

Not cited in a single tracked AI answer since Jun 13, 2026, down from a peak of 8% visibility in ozempic on Jun 13, 2026. This page and its history stay public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Ozempic, daily share of AI answers mentioning Hims & Hers Health, through Jun 14, 2026.

0.0%

Last cited Jun 13, 2026 · peak 8% on Jun 13

By engine

Where Hims & Hers Health is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Hims & Hers Health

PerplexityJun 13, 2026, 11:12 UTC
What are the best alternatives if I cannot get Ozempic, and who prescribes them online?

Based on current medical guidelines and available online services (as of 2026), here are the best alternatives to Ozempic (semaglutide) and information on which providers prescribe them online. Best Alternatives to Ozempic If you cannot access Ozempic, the most effective alternatives are other GLP-1 receptor agonists or dual GIP/GLP-1 agonists. These work similarly by regulating appetite and blood sugar. FDA-Approved Injectable Alternatives (Weight Loss) Wegovy (Semaglutide): The most direct alternative. It contains the exact same active ingredient as Ozempic but is FDA-approved specifically for chronic weight management. Dosage:* Starts at 0.25 mg/week, increasing to 2.4 mg/week. Zepbound (Tirzepatide): A newer, highly effective dual GIP/GLP-1 agonist. Clinical data often shows it leads to greater weight loss than semaglutide alone. Dosage:* Starts at 2.5 mg/week, increasing to 15 mg/week. Saxenda (Liraglutide): An older GLP-1 agonist approved for weight management (since 2014). It is effective but generally requires daily injections rather than weekly. Note:* An authorized generic of liraglutide (active ingredient in Saxenda/Victoza) is now available, potentially lowering costs. FDA-Approved Oral Alternative Rybelsus (Semaglutide): The first oral GLP-1 medication. It contains the same active ingredient as Ozempic and Wegovy. Use:* Primarily FDA-approved for Type 2 diabetes but often prescribed for weight loss. Benefit:* Ideal for patients who dislike needles. Other Prescription Options (Non-GLP-1) If GLP-1s are not accessible or suitable, doctors may prescribe: Contrave (Naltrexone-Bupropion): Combines two drugs to affect brain appetite/reward centers. Orlistat (Xenical/Alli): Blocks fat absorption. (Xenical is prescription; Alli is OTC). Phentermine (Adipex/Suprenza): A short-term stimulant for appetite suppression. Metformin: Often used for Type 2 diabetes; sometimes prescribed off-label for weight management (less effective than GLP-1s). Who Prescribes Them Online? Several reputable telehealth platforms specialize in weight loss and can evaluate you via video or questionnaire to prescribe these medications. Important Note: Legitimate providers will not prescribe these medications without a review of your medical history, and they often require a recent blood test (which can be done at a local lab like Quest or LabCorp) to ensure safety. Top Telehealth Providers for Weight Loss: Ro (formerly Ross Health): What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Dedicated "Go" program for weight loss; offers medication management and coaching. Hims & Hers Health: What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Integrates medication with lifestyle coaching; very popular for online prescriptions. Klarity (Klarity Health): What they prescribe:* Wegovy, Zepbound, Saxenda, and Rybelsus. Approach:* Focuses on connecting patients with local doctors for telehealth visits. Wellness Wanderer (or similar specialized clinics): Many specialized obesity medicine clinics (like Obesity Medicine Association members) offer remote consultations. NovoCare Pharmacy & LillyDirect: Note: These are manufacturer programs, not prescribers. If you have a prescription from any* doctor (online or in-person), you can use these services to get Wegovy or Zepbound shipped directly, often at a lower cash price (e.g., $650 for Wegovy, $399–$650 for Zepbound). How to Get Prescribed Online: Sign Up: Choose a provider (e.g., Ro, Hims, Hers). Medical Review: Complete a health questionnaire and undergo a telehealth video consultation with a licensed provider (MD, DO, or NP). Lab Work: The provider may order a blood test (AST/ALT, kidney function, etc.) to be done at a local lab. Prescription: If approved, the medication is shipped to your home or sent to a local pharmacy for pickup. Monitoring: You will need ongoing monthly or quarterly check-ins to monitor progress and adjust dosages. Cost Considerations & Compounding Savings Coupons: Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) offer savings programs for cash-paying patients without insurance coverage for obesity drugs. Compounded Medications: Some telehealth providers offer compounded versions of semaglutide or tirzepatide as a cheaper alternative. However, the FDA has issued warnings about compounded GLP-1s regarding safety and purity. Always verify the provider's accreditation. Authorized Generics: If you switch to Saxenda, ask your doctor about the authorized generic liraglutide, which is significantly cheaper than the branded version. Summary Recommendation If you want the closest alternative with the same efficacy, Wegovy is the top choice. If you want the highest potential for weight loss, Zepbound is the best option. If you refuse injections, Rybelsus is your go-to. For online prescribing, Ro, Hims & Hers, and Klarity are the most established and reliable platforms for these specific medications in 2026. Always consult with a healthcare professional to ensure these medications are safe for your specific health profile.

Mentioned in position 2 of 10

Read full answer with sources →

Public AI visibility history

Daily rank of Hims & Hers Health on our buyer intent questions, per category. A dash means the engines did not cite Hims & Hers Health at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13Jun 14
Ozempic#50

TL;DR

Hims & Hers Health is a publicly traded direct-to-consumer telehealth company best known for offering prescription and OTC treatments across sexual health, hair loss, mental health, and weight management. It operates through its flagship site forhims.com and a sister brand for women. In WellRank's latest index it ranks 15th in Ozempic-related AI answers with 8% visibility, and its single scored mention in the AI corpus carries a positive tone, suggesting early but favorable surfacing in GLP-1 and weight-loss conversations.

Company Overview

Hims & Hers Health connects patients with licensed clinicians through an online platform that prescribes, dispenses, and ships treatments directly to consumers, cutting out the traditional in-person clinic visit. The company is headquartered in San Francisco and trades on the New York Stock Exchange under the ticker HIMS. Its model bundles telehealth consultations with an affiliated pharmacy network, generating revenue primarily through subscription and one-time product purchases.

Product Features

  • Prescription weight-loss treatments including compounded GLP-1 medications
  • Hair loss medications such as finasteride and minoxidil
  • Erectile dysfunction treatments including sildenafil and tadalafil
  • Mental health services with online therapy and psychiatry prescriptions
  • Skincare and dermatology prescriptions via async or live consults
  • Women's health offerings including birth control and menopause support

Target Market

Hims & Hers primarily serves adults in the United States who prefer managing routine or sensitive health conditions discreetly online rather than through in-person visits. Core condition categories include sexual health, hair loss, weight management, and mental health. The platform is designed for patients comfortable with app- or web-based care and home delivery of prescriptions.

Buyer Personas

  • A millennial man seeking a discreet, no-appointment path to ED or hair-loss prescriptions without a clinic visit.
  • A woman in her 30s or 40s looking for convenient birth control refills or menopause symptom management from home.
  • A consumer who has heard about GLP-1 weight-loss drugs and wants an affordable, online-first route to evaluation and a prescription.
  • A young professional managing anxiety or depression who wants an asynchronous mental health consultation and ongoing medication management.

Funding & Performance

Hims & Hers went public in January 2021 via a SPAC merger with Oaktree Acquisition Corp and is listed on the NYSE as HIMS. As a public company its financials are disclosed in SEC filings; specific revenue figures and market capitalization fluctuate and should be verified through current filings rather than cited here as fixed numbers.

Recent Developments

The company has expanded meaningfully into weight management, adding compounded GLP-1 medications to its platform as demand for Ozempic alternatives surged, which aligns with its current surfacing in AI answers on that topic. Hims & Hers has also broadened its affiliated pharmacy infrastructure to support faster fulfillment. Ongoing product development has focused on personalized or combination formulations across several therapeutic areas, and the brand has invested in direct-response marketing that extends its reach into new demographics.

Competitive Landscape

In WellRank's co-mention data, AI engines most often name Hims & Hers alongside Ro, LillyDirect, and Klarity on the telehealth side, and alongside Novo Nordisk, NovoCare Pharmacy, and the Obesity Medicine Association in clinical and manufacturer contexts. Sources that engines cite in answers featuring the brand, such as GoodRx's GLP-1 alternatives guide and Health.com's coverage of cheaper Ozempic alternatives, place it in a crowded field of platforms competing on price, access, and convenience for weight-loss prescriptions.

Mentioned alongside

Brands AI engines recommend in the same breath. Your real competitive set.

User Sentiment

Hims & Hers carries a positive tone in the AI corpus tracked by WellRank, with its one scored mention being favorable rather than cautious or mixed. Third-party comparisons indexed by AI engines, including resources from Stanford Medicine on GLP-1 developments and community-facing guides like Joinlevity's Ozempic alternatives post, tend to position the brand as a legitimate, accessible option rather than a risky one, though the overall volume of AI mentions is still low at 8% visibility.

Pricing

Hims & Hers uses a mix of subscription and one-time purchase pricing that varies by treatment category. Specific prices for GLP-1 and other prescription services are not published as stable list prices and change based on medication availability, insurance status, and promotional offers, so buyers should consult the platform directly for current quotes.

Sources cited around Hims & Hers Health

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Hims & Hers Health weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Hims & Hers Health? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.